Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Not Applicable
Completed
- Conditions
- Hepatic Encephalopathy
- Interventions
- First Posted Date
- 2010-10-11
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 120
- Registration Number
- NCT01218568
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 132
- Registration Number
- NCT01212250
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.
Not Applicable
Completed
- Conditions
- Cirrhosis
- Interventions
- Drug: Carvedilol+VSL#3Procedure: Endoscopic variceal ligation
- First Posted Date
- 2010-09-08
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 40
- Registration Number
- NCT01196481
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
Early Primary Prophylaxis of Esophageal Varices
- First Posted Date
- 2010-09-08
- Last Posted Date
- 2016-06-15
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 140
- Registration Number
- NCT01196507
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
© Copyright 2025. All Rights Reserved by MedPath